First dates are tough enough, but one couple’s first outing turned
Researchers discover first treatment to improve survival in rare heart condition
Tafamidis is the first treatment to improve survival and reduce
First drug approved for rare eye disease
(HealthDay)—Oxervate (cenegermin) has been approved by the U.S. Food and
Orphazyme Announces Enrollment of First Patient in Phase III Clinical Trial of Arimoclomol for ALS
Copenhagen, August 10, 2018 – Orphazyme A/S, a biopharmaceutical company
First study on physical properties of giant cancer cells may inform new treatments
Polyploidal cancer cells—cells that have more than two copies of
Virtual reality may help students experience life with dementia first hand
Virtual reality technology gives high school students greater insight into